Top compounds associated with response to DPY19L4


Feature Type Standardized
Nominal ANOVA
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.085 0.02
mRNA barasertib CTRPv2 pan-cancer AAC 0.078 0.02
mRNA RAF265 CCLE pan-cancer AAC 0.12 0.02
mRNA nintedanib CTRPv2 pan-cancer AAC 0.09 0.02
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.083 0.02
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.082 0.02
mRNA TAE684 CCLE pan-cancer AAC 0.11 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.02
mRNA AZD0530 CCLE pan-cancer AAC 0.12 0.02
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
Download CSV